Near Patient Working Party Agendas: what would you like to see? Membership NewsMembership News Archive

Near Patient Working Party Agendas: what would you like to see?

The Near Patient Testing (NPT) Working Party exists to keep members up to date with the latest news, regulations, innovations and implementations that are happening in the field of point of care diagnostics. We meet face to face several times a year in the BIVDA offices, and if you haven't ever attended - maybe 2025 is the year you start!…
Ben Kemp
February 4, 2025
BIVDA and NHSE Diag Task and Finish Group – Innovation in Pathology Managed Services Membership NewsMembership News Archive

BIVDA and NHSE Diag Task and Finish Group – Innovation in Pathology Managed Services

BIVDA is leading a Task and Finish Group under the NHS England Diagnostics Advisory Group programme which aims to test the hypothesis that the current NHS pathology Managed Equipment Service contracts restrict the procurement and adoption of new and innovative technologies in IVD markets. Currently, smaller companies and less established products struggle to gain market access through these contracts. The…
Ben Kemp
February 4, 2025
UKHSA Diagnostics and Research Open Framework – Market Engagement Membership NewsMembership News Archive

UKHSA Diagnostics and Research Open Framework – Market Engagement

The UKHSA Diagnostics and Research Open Framework will be tendered later this year and ahead of that procurement UK Health and Security Agency’s (UKHSA) Scientific Procurement team wishes to conduct a market engagement exercise. This consultation is intended to enhance the procurement team’s understanding of the current market in advance of the tendering of the open framework agreement later in…
Ben Kemp
February 4, 2025
Biocides: Upcoming active substance renewals, expiries and approvals European Commission Updates Regulatory Affairs NewsletterEuropean Commission Updates Regulatory Affairs Newsletter ArchiveRegulatory Affairs NewsletterRegulatory Affairs Newsletter ArchiveUK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

Biocides: Upcoming active substance renewals, expiries and approvals

Apply for active substance renewal by the deadlines to keep products on the NI market 29 April 2025 Polyhexamethylene biguanide hydrochloride with a mean number-average molecular weight (Mn) of 1415 and a mean polydispersity (PDI) of 4.7 (PHMB (1415;4.7)) (CAS 1802181-67-4 / 32289-58-0 EC n/a) in product types 2 and 4 30 July 2025 Hydrogen peroxide (CAS 7722-84-1 EC 231-765-0)…
Ben Kemp
February 3, 2025
EU Health Policy Platform: The 2024 Thematic Networks cycle has come to an end – what’s next? European Commission Updates Regulatory Affairs NewsletterEuropean Commission Updates Regulatory Affairs Newsletter ArchiveRegulatory Affairs NewsletterRegulatory Affairs Newsletter Archive

EU Health Policy Platform: The 2024 Thematic Networks cycle has come to an end – what’s next?

EU Health Policy Platform: The 2024 Thematic Networks cycle has come to an end – what’s next? The 2024 Thematic Networks are now being transformed into Stakeholder and Exchange Networks, but you can continue to share your views and provide input on the health topics they deal with. The Joint Statements on which the Thematic Networks have been working on…
Ben Kemp
February 3, 2025
Joint Action on Networks of Expertise on Cancer launched European Commission Updates Regulatory Affairs NewsletterEuropean Commission Updates Regulatory Affairs Newsletter ArchiveRegulatory Affairs NewsletterRegulatory Affairs Newsletter Archive

Joint Action on Networks of Expertise on Cancer launched

Joint Action on Networks of Expertise on Cancer launched Today, the second Joint Action of the EU Networks of Expertise on Cancer (JANE-2) has been launched. This is one of the largest Joint Actions on cancer, supported by EUR 40.5 million in funding from the EU4Health programme. JANE-2 has 121 partners from 29 European countries and is coordinated by Italy.…
Ben Kemp
February 3, 2025